Professor Pierre J Lefèbvre, MD, PhD, University of Liege, Belgium

Professor Lefèbvre is Emeritus Professor of Internal Medicine at the University of Liege, Belgium, as well as Consultant at the Division of Internal Medicine at the University Hospital, Liege. Professor Lefèbvre is widely recognized for his leadership in multiple areas of diabetes, including pioneering research on glucagon physiology and intermediary metabolism using stable isotope methods in humans. Professor Lefèbvre maintains a distinguished career in education and clinical care, and is highly recognized for the leadership role he has played in numerous national and international organizations promoting research, education and improved care for people with diabetes worldwide.

 

 

Professor Gerald M Reaven, MD, Stanford School of Medicine, USA

Professor Reaven is Professor of Medicine (Active Emeritus) at the Division of Cardiovascular Medicine, Stanford School of Medicine, California, USA. During the past 35 years, Professor Reaven has developed the now widely accepted concept that insulin resistance and hyperinsulinemia are both associated with an array of metabolic disorders that include type 2 diabetes mellitus, hypertension, dyslipidemia, hyperuricemia, and altered coagulation and fibrinolysis. All such disorders contribute to increased atherosclerosis and cardiovascular disease. Professor Reaven coined the term 'Syndrome X' for this condition, which is now more commonly called the 'Insulin Resistance Syndrome'. Professor Reaven's work has been seminal in demonstrating the linkage between insulin resistance, hyperinsulinemea and cardiovascular disease in patients with 'Syndrome X' or type 2 diabetes.